A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
- Conditions
- Interventions
- First Posted Date
- 2021-08-03
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 776
- Registration Number
- NCT04988295
- Locations
- 🇳🇱
VUMC Amsterdam, Amsterdam, Netherlands
🇲🇽Instituto Nacional de Cancerologia, Mexico, Mexico
🇲🇽Oncologia Integral Satelite, Naucalpan, Mexico
A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 3
- First Posted Date
- 2021-08-02
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 12
- Registration Number
- NCT04985955
- Locations
- 🇧🇪
Clinical Pharmacology Unit, Merksem, Belgium
A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis
- First Posted Date
- 2021-08-02
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 44
- Registration Number
- NCT04985812
- Locations
- 🇭🇺
Clinexpert Kft, Gyöngyös, Hungary
🇭🇺Budai Irgalmasrendi Korhaz, Budapest, Hungary
🇭🇺CRU Hungary Kft., Kistarcsa, Hungary
A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection
- First Posted Date
- 2021-07-27
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 5
- Registration Number
- NCT04978337
- Locations
- 🇺🇸
Pines Care Research Center Inc, Pembroke Pines, Florida, United States
🇺🇸Renovatio Clinical, The Woodlands, Texas, United States
🇺🇸Frontier Clinical Research, Morgantown, West Virginia, United States
A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy Participants
- Conditions
- Interventions
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2023-07-03
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT04973566
- Locations
- 🇳🇱
PRA Health Sciences, Groningen, Netherlands
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)
- Conditions
- Interventions
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 163
- Registration Number
- NCT04968912
- Locations
- 🇺🇸
St. Paul Rheumatology P A, Eagan, Minnesota, United States
🇪🇸Hosp Reina Sofia, Córdoba, Spain
🇪🇸Hosp Univ A Coruna, La Coruña, Spain
A Study of JNJ-73763989 in Adult Participants With Renal Impairment
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 29
- Registration Number
- NCT04963738
- Locations
- 🇩🇪
CRS Clinical Research Services Kiel GmbH, Kiel, Germany
A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants
- First Posted Date
- 2021-07-13
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT04960124
- Locations
- 🇩🇪
APEX GmbH, Munchen, Germany
🇩🇪CRS Clinical Research Services Kiel GmbH, Kiel, Germany
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- First Posted Date
- 2021-07-07
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 198
- Registration Number
- NCT04951622
- Locations
- 🇺🇸
Neuromuscular Research Center and Clinic, Paradise Valley, Arizona, United States
🇺🇸HonorHealth Neurology, Scottsdale, Arizona, United States
🇺🇸University of Southern California, Los Angeles, California, United States
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy
- First Posted Date
- 2021-07-07
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 31
- Registration Number
- NCT04951609
- Locations
- 🇺🇸
CincyScience, West Chester, Ohio, United States
🇺🇸Southwest Autism Research and Resource Center, Phoenix, Arizona, United States
🇺🇸Yale University, New Haven, Connecticut, United States